LEGISLATIVE BUDGET BOARD
Austin, Texas
 
FISCAL NOTE, 86TH LEGISLATIVE REGULAR SESSION
 
April 15, 2019

TO:
Honorable James B. Frank, Chair, House Committee on Human Services
 
FROM:
John McGeady, Assistant Director     Sarah Keyton, Assistant Director
Legislative Budget Board
 
IN RE:
HB3707 by Parker (Relating to value-based arrangements for prescription drugs in Medicaid.), As Introduced

The fiscal implications of the bill cannot be determined at this time, but there could be a positive fiscal impact to the state.

The bill would authorize the Health and Human Services Commission to enter into certain value-based arrangements with prescription drug manufacturers. It is assumed any administrative costs associated with implementation of the bill would be minimal and could be absorbed within the available resources of the agency. The fiscal impact of the value-based arrangements cannot be determined but if implemented, they would be expected to either reduce costs or increase rebate revenue resulting in a positive fiscal impact to the state.

Local Government Impact

No significant fiscal implication to units of local government is anticipated.


Source Agencies:
529 Health and Human Services Commission
LBB Staff:
WP, AKi, LR